Head-to-head · WeighScore
Basal Health vs HealthRX
The verdict
HealthRX takes it — 86.1/100 to 47.7/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Basal Health | HealthRX |
|---|---|---|
| WeighScore | 47.7/100 | 86.1/100 |
| Grade | C | B |
| Scorecard rank | #494 | #8 |
| Semaglutide | Not disclosed | $189/mo |
| Tirzepatide | Not disclosed | $349/mo |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #494 · C
Strengths
- Stated nationwide coverage (50 states + DC)
- Metabolic-framework positioning rather than single-product
- Clinician-supervised dosing rather than a fixed protocol
- Adaptive monitoring approach
Where it loses points
- No pricing shown publicly — you must complete intake to see cost
- Compounding pharmacy partner not named
- GLP-1 molecules not specified (semaglutide vs tirzepatide vs oral)
- No LegitScript badge visible on the homepage
- No FDA compounded-medication disclaimer on the pages reviewed
Graded #8 · B
Strengths
- LegitScript-certified (#50087439) — a genuine, verifiable trust signal
- Physician-supervised intake with licensed providers
- Both molecules plus a rare oral GLP tablet option
- Transparent flat monthly pricing, no insurance required
Where it loses points
- Compounded semaglutide/tirzepatide is not FDA-approved
- Some tiers are company-stated and the public site is thin
- Brand Ozempic is a steep pass-through (~$1,299)
- State count is not publicly listed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.